Nectar Lifesciences Ltd (NECLIFE)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 14.13
% Change: -0.14% (Prev Close: 14.15)

Volume: 2,16,648
% Change: -21.65% (Prev Volume: 2,76,519)

Delivery: 0
Delivery % : 0.00
% Change: 0.00% (Prev Delivery: 0)

Turnover: 31 Lacs
% Change: -22.47% (Prev Turnover: 39)

πŸ’Ή EOD Valuation

P/E Ratio: 0.00
P/B Ratio: 0.33
Market Cap: 317 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: NECLIFE
Market Cap: 320 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 56.50
52 Week Low: 13.05

All-Time High: 60.90 Rs.
All-Time Low: 7.10 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-1.83% | -40.21% | -50.39% | -63.80% | -14.50%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 44.53%

Change (3Y | 1Y): 0.18% | 0.00%

Pledged %: 99.60%

FII Holding

FII Holding: 0.82%

Change (3Y | 1Y): -0.67% | -0.83%

DII Holding

DII Holding: 0.19%

Change (3Y | 1Y): 0.19% | 0.04%

Public Holding: 54.45%

🏦 Financial Strength

Debt to Equity: 0.61
Debt: 582.02 Rs. Cr.

Book Value: 42.63 Rs.
Current Ratio: 1.21
Interest Coverage: -2.59
Free Cash Flow: 125.65 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: -3.41%

Sales Growth Qtr (YOY | QoQ):
-21.88% | -34.83%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-6.77% | -0.01% | -3.41%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: -3024.88%

Profit Growth Qtr (YOY | QoQ):
-2228.96% | 51.40%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
0.00% | 0.00% | -3024.88%

EPS Rs.

EPS (TTM): -8.02 Rs.

EPS Qtr (Last Year | Latest):
0.13 Rs. | -2.82 Rs.

EPS Annual (Last Annual | Annual March):
0.22 Rs. | -5.07 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
0.00% | 0.00%

Net Profit Rs. Cr.

Net Profit (TTM): -179.88 Rs. Cr.

Net Profit (Annual - March): -113.68 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
2.97| -130.09 | -63.23

EBITDA Rs. Cr.

EBITDA (Quarter): -61.54 Rs. Cr.
EBITDA (Previous Yr Ql): 40.36 Rs. Cr.

EBITDA (Annual - March): -24.59 Rs. Cr.
EBITDA (Previous Annual): 165.95 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
0.00% | 0.00%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): -8.04%

OPM Qtr (Previous | Current):
-35.83% | -22.05%

OPM Annual (5 Yrs | Last Yr | March):
5.49% | 9.01% | -1.77%

Return on Equity %

ROE: -11.23%

ROE (5 Yrs | 3 Yrs | Last Yr):
-3.81% | -5.50% | 0.46%

Return on Capital Employed %

ROCE: -5.36%

ROCE (5 Yrs | 3 Yrs | Last Yr):
1.69% | 0.14% | 5.97%

Return on Assets %

ROA (TTM): -5.37%

ROA (5 Yrs | 3 Yrs | Last Yr):
-1.82% | -2.66% | 0.22%

PEG Ratio: 0.00
Dividend Yield: 0.00%

PE 3 Yrs: 94.65
PE 5 Yrs: 83.61

Dividend Yield: 0.00%

πŸ‘₯ Company

Nectar Lifesciences Ltd

NECLIFE

Promoter Holding: %